Reaction
Pituitary Tumour Benign reporting signals
As of the last recalculation, Pituitary Tumour Benign appears in 1,620 FAERS reports alongside 35 co-occurring drug terms. The strongest observed disproportionality signal is LANREOTIDE ACETATE (PRR 60.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lanreotide Acetate | 36 | 60.3 | 60.6 |
| Quetiapine Fumarate | 69 | 31.3 | 31.4 |
| Somatropin | 158 | 30.5 | 30.6 |
| Octreotide Acetate | 58 | 25.2 | 25.2 |
| Anti-Itch | 98 | 19.9 | 20.0 |
| Anti-Pruritic | 98 | 19.9 | 20.0 |
| Antipruritic (Anti-Itch) | 98 | 19.9 | 20.0 |
| Cool Relief Gel With Aloe | 98 | 19.9 | 20.0 |
| Drs. Hydrocortisone | 98 | 19.9 | 20.0 |
| Hydrocortisone Continuous Spray | 98 | 19.9 | 20.0 |
| Hydrocortisone Spray | 98 | 19.9 | 20.0 |
| Anti-Itch Cream | 98 | 19.9 | 20.0 |
| Hydrocortisone Lotion | 98 | 19.9 | 20.0 |
| Hydrocortisone Cream 1% | 98 | 19.9 | 19.9 |
| Hydrocortisone Cream 1/2% | 98 | 19.9 | 19.9 |
| Hydrocortisone 1% | 98 | 19.9 | 19.9 |
| Hydrocortisone Cream | 98 | 19.8 | 19.9 |
| Hydrocortisone Acetate | 103 | 19.4 | 19.4 |
| Testosterone | 32 | 17.9 | 17.9 |
| Hydrocortisone | 112 | 17.2 | 17.3 |
| Risperidone | 160 | 17.0 | 17.1 |
| Sumatriptan Succinate | 32 | 16.6 | 16.6 |
| Goserelin | 13 | 12.5 | 12.5 |
| Levothyroxine Sodium Anhydrous | 82 | 11.0 | 11.0 |
| Sumatriptan | 32 | 11.0 | 11.0 |
| Haloperidol Lactate | 20 | 10.5 | 10.5 |
| Haloperidol | 19 | 10.2 | 10.2 |
| Ziprasidone | 13 | 9.6 | 9.6 |
| Paliperidone Palmitate | 23 | 9.3 | 9.3 |
| Bicalutamide | 10 | 8.5 | 8.5 |
| Paliperidone | 15 | 8.3 | 8.3 |
| Ziprasidone Mesylate | 7 | 6.3 | 6.3 |
| Cortisone Acetate | 6 | 6.3 | 6.3 |
| Brexpiprazole | 6 | 4.7 | 4.7 |
| Lurasidone Hydrochloride | 7 | 4.3 | 4.3 |